Charlotte C M Van Laake-Geelen, Rob J E M Smeets, Thijs Van Meulenbroek, Marlies Den Hollander, Marielle E J B Goossens, Jeanine A Verbunt
{"title":"疼痛性糖尿病神经病变患者的“体内暴露”生物心理社会康复治疗:治疗方案的制定。","authors":"Charlotte C M Van Laake-Geelen, Rob J E M Smeets, Thijs Van Meulenbroek, Marlies Den Hollander, Marielle E J B Goossens, Jeanine A Verbunt","doi":"10.2340/20030711-1000015","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Painful diabetic neuropathy is associated with low quality of life, depression and anxiety. Patients are limited in their performance of activities of daily living due to fears related to their condition. Treatment modalities are needed to help patients cope with their pain and pain-related disability. Exposure <i>in vivo</i> is an effective treatment in other chronic pain syndromes, increasing patients' functional ability and quality of life. This paper presents an Exposure <i>in vivo</i> treatment protocol for patients with painful diabetic neuropathy.</p><p><strong>Protocol: </strong>An 8-week Exposure <i>in vivo</i> treatment protocol was specifically adapted to the needs and risks of patients with painful diabetic neuropathy. New screening tools were developed for patients with PDN; the Painful Diabetic Neuropathy Anxiety Rasch-Transformed Questionnaire (PART-Q30) identifies specific fears related to painful diabetic neuropathy (e.g. fear of hypoglycaemia); and a customized version of the Photograph-series Of Daily Activities (PHODA-PDN) detects fear-eliciting activities related to the condition in individual patients. During Exposure <i>in vivo</i>, catastrophic interpretations regarding painful stimuli are challenged and corrected, thereby diminishing pain-related fear and enabling the patient to re-engage in activities of daily living. An interdisciplinary team provides Exposure <i>in vivo</i> in 1-h sessions twice a week.</p><p><strong>Discussion: </strong>To the best of our knowledge, this treatment protocol is the first intervention using Exposure <i>in vivo</i> specifically adapted to the needs and risks of patients with painful diabetic neuropathy.</p>","PeriodicalId":73929,"journal":{"name":"Journal of rehabilitation medicine. Clinical communications","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2019-06-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2340/20030711-1000015","citationCount":"0","resultStr":"{\"title\":\"Biopsychosocial Rehabilitation Treatment \\\"Exposure <i>In Vivo</i>\\\" for Patients with Painful Diabetic Neuropathy: Development of a Treatment Protocol.\",\"authors\":\"Charlotte C M Van Laake-Geelen, Rob J E M Smeets, Thijs Van Meulenbroek, Marlies Den Hollander, Marielle E J B Goossens, Jeanine A Verbunt\",\"doi\":\"10.2340/20030711-1000015\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>Painful diabetic neuropathy is associated with low quality of life, depression and anxiety. Patients are limited in their performance of activities of daily living due to fears related to their condition. Treatment modalities are needed to help patients cope with their pain and pain-related disability. Exposure <i>in vivo</i> is an effective treatment in other chronic pain syndromes, increasing patients' functional ability and quality of life. This paper presents an Exposure <i>in vivo</i> treatment protocol for patients with painful diabetic neuropathy.</p><p><strong>Protocol: </strong>An 8-week Exposure <i>in vivo</i> treatment protocol was specifically adapted to the needs and risks of patients with painful diabetic neuropathy. New screening tools were developed for patients with PDN; the Painful Diabetic Neuropathy Anxiety Rasch-Transformed Questionnaire (PART-Q30) identifies specific fears related to painful diabetic neuropathy (e.g. fear of hypoglycaemia); and a customized version of the Photograph-series Of Daily Activities (PHODA-PDN) detects fear-eliciting activities related to the condition in individual patients. During Exposure <i>in vivo</i>, catastrophic interpretations regarding painful stimuli are challenged and corrected, thereby diminishing pain-related fear and enabling the patient to re-engage in activities of daily living. An interdisciplinary team provides Exposure <i>in vivo</i> in 1-h sessions twice a week.</p><p><strong>Discussion: </strong>To the best of our knowledge, this treatment protocol is the first intervention using Exposure <i>in vivo</i> specifically adapted to the needs and risks of patients with painful diabetic neuropathy.</p>\",\"PeriodicalId\":73929,\"journal\":{\"name\":\"Journal of rehabilitation medicine. Clinical communications\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-06-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.2340/20030711-1000015\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of rehabilitation medicine. Clinical communications\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2340/20030711-1000015\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2019/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of rehabilitation medicine. Clinical communications","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2340/20030711-1000015","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2019/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
Biopsychosocial Rehabilitation Treatment "Exposure In Vivo" for Patients with Painful Diabetic Neuropathy: Development of a Treatment Protocol.
Objective: Painful diabetic neuropathy is associated with low quality of life, depression and anxiety. Patients are limited in their performance of activities of daily living due to fears related to their condition. Treatment modalities are needed to help patients cope with their pain and pain-related disability. Exposure in vivo is an effective treatment in other chronic pain syndromes, increasing patients' functional ability and quality of life. This paper presents an Exposure in vivo treatment protocol for patients with painful diabetic neuropathy.
Protocol: An 8-week Exposure in vivo treatment protocol was specifically adapted to the needs and risks of patients with painful diabetic neuropathy. New screening tools were developed for patients with PDN; the Painful Diabetic Neuropathy Anxiety Rasch-Transformed Questionnaire (PART-Q30) identifies specific fears related to painful diabetic neuropathy (e.g. fear of hypoglycaemia); and a customized version of the Photograph-series Of Daily Activities (PHODA-PDN) detects fear-eliciting activities related to the condition in individual patients. During Exposure in vivo, catastrophic interpretations regarding painful stimuli are challenged and corrected, thereby diminishing pain-related fear and enabling the patient to re-engage in activities of daily living. An interdisciplinary team provides Exposure in vivo in 1-h sessions twice a week.
Discussion: To the best of our knowledge, this treatment protocol is the first intervention using Exposure in vivo specifically adapted to the needs and risks of patients with painful diabetic neuropathy.